The Value of Rivaroxaban Combined with Ticagrelor in Antithrombotic Therapy after PCI in Patients with Nonvalvular Atrial Fibrillation with Acute Coronary Syndrome

OBJECTIVE: Based on a retrospective cohort study, to investigate the value of rivaroxaban combined with ticagrelor in antithrombotic therapy after PCI in patients with nonvalvular atrial fibrillation with acute coronary syndrome. METHODS: A total of 60 patients from January 2019 to May 2021 accepted...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhengwang, Qiu, Xiaotang, Yang, Hua, Wu, Xiaocui, Ye, Wenjing, Zheng, Xinbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649311/
https://www.ncbi.nlm.nih.gov/pubmed/36387358
http://dx.doi.org/10.1155/2022/4807175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649311/
https://www.ncbi.nlm.nih.gov/pubmed/36387358
http://dx.doi.org/10.1155/2022/4807175

Ejemplares similares